Press Releases

Date	Title	Company
11-Sep-2022	Blood Clot Retrieval Devices Market Size Will Achieve USD 5.6 Billion By 2030 Growing At 18.4% CAGR - Exclusive Report by Acumen Research and Consulting	Acumen Research And Consulting
11-Sep-2022	Behavioral Health Market Size To Gain USD 267 Billion Revenue By 2030 Growing At 2.5% CAGR – According To A Report By Acumen Research And Consulting	Acumen Research And Consulting
11-Sep-2022	Five-Year Data for Merck's KEYTRUDA® (pembrolizumab) Plus Chemotherapy Showed Sustained Survival Benefit Versus Chemotherapy Alone in Two Studies for Metastatic Non-Small Cell Lung Cancer (NSCLC)	Businesswire
11-Sep-2022	Hypertension Drugs Market Size To Gain USD 34,072 Million Revenue By 2030 At 3.4% CAGR During 2022 to 2030	Acumen Research And Consulting
11-Sep-2022	ENT Treatment Market Size to Gain USD 33.9 Billion Revenue By 2030 At a CAGR 5.5% from 2022 to 2030	Acumen Research And Consulting
10-Sep-2022	Bicara Therapeutics Presents New Data from Ongoing Phase 1/1b Trial of Lead First-in-Class Bifunctional Program, BCA101, at the European Society for Medical Oncology (ESMO) Congress 2022	Businesswire
10-Sep-2022	Spectrum Pharmaceuticals Announces Data from Poster Presentation for Poziotinib in NSCLC Patients with G778_P780dup HER2 Exon 20 Mutations at ESMO Congress 2022	Businesswire
10-Sep-2022	Wugen Presents Preclinical Data on WU-NK-101 in Solid Tumor Models at the European Society for Medical Oncology (ESMO) Congress 2022	Businesswire
10-Sep-2022	Exelixis Announces Dose-Escalation Results from the Phase 1 STELLAR-001 Trial Evaluating XL092 Alone and in Combination with an Immune Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ESMO 2022	Businesswire
10-Sep-2022	Bristol Myers Squibb Announces New Sotyktu™ (deucravacitinib) Long-Term Data Showing Clinical Efficacy Maintained for Up to Two Years with Continuous Treatment in Moderate-to-Severe Plaque Psoriasis	Businesswire
10-Sep-2022	BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line Unresectable Hepatocellular Cancer	Businesswire
10-Sep-2022	U.S. Food and Drug Administration Approves Sotyktu™ (deucravacitinib), Oral Treatment for Adults with Moderate-to-Severe Plaque Psoriasis	Businesswire
10-Sep-2022	MarketVector Indexes™ Announces Quarterly and Semi-Annual Index Review Results for Q3 2022	Businesswire
10-Sep-2022	Antibe Announces Results of 2022 Annual Meeting	Businesswire
09-Sep-2022	Spectrum Pharmaceuticals Receives FDA Approval for ROLVEDON™ (eflapegrastim-xnst) Injection	Businesswire
09-Sep-2022	Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)	Businesswire
09-Sep-2022	Global Irritable Bowel Syndrome with Constipation Drugs Market Report to 2030 - Featuring Abbott Laboratories, AstraZeneca and Sanofi Among Others - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Outlook on the Smart Manufacturing Global Market to 2028 - Featuring ABB, Honeywell International, Rockwell Automation and Siemens Among Others - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Americas Pipe Insulation Market to Reach $3.91 Billion by 2030 - ResearchAndMarkets.com	Businesswire
09-Sep-2022	Global Empty Capsules Market Report 2022: Development of Halal Gelatin Capsules Presents Opportunities - ResearchAndMarkets.com	Businesswire